About Silvergate Pharma
Silvergate Pharma is a company based in Greenwood Village (United States) founded in 2010 was acquired by Azurity Pharmaceuticals in June 2019.. Silvergate Pharma has raised $30.75 million across 4 funding rounds from investors including Frazier Healthcare Partners and Azurity Pharmaceuticals. Silvergate Pharma operates in a competitive market with competitors including Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others.
- Headquarter Greenwood Village, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30.75 M (USD)
in 4 rounds
-
Latest Funding Round
$4.6 M (USD), Series B
Oct 03, 2016
-
Investors
Frazier Healthcare Partners
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Azurity Pharmaceuticals
(Jun 12, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Software Development Team
39 people
Leadership Team
29 people
Sales and Marketing
13 people
Product Management Team
8 people
Senior Team
8 people
Data Analysis and Operations Team
8 people
Operations Team
5 people
Human Resources and Administration
4 people
Unlock access to complete
Funding Insights of Silvergate Pharma
Silvergate Pharma has successfully raised a total of $30.75M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $4.6 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $4.6M
-
First Round
First Round
(13 Jun 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Series B - Silvergate Pharma | Valuation |
investors |
|
| Oct, 2015 | Amount | Series B - Silvergate Pharma | Valuation |
investors |
|
| Sep, 2014 | Amount | Series B - Silvergate Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Silvergate Pharma
Silvergate Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Frazier Healthcare Partners and Azurity Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Generic drugs are manufactured by Azurity Pharmaceuticals in the US.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Silvergate Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Silvergate Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Silvergate Pharma Comparisons
Competitors of Silvergate Pharma
Silvergate Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for cardiovascular and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Innovative pharmaceuticals for cardiovascular and metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Silvergate Pharma
Frequently Asked Questions about Silvergate Pharma
When was Silvergate Pharma founded?
Silvergate Pharma was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is Silvergate Pharma located?
Silvergate Pharma is headquartered in Greenwood Village, United States. It is registered at Greenwood Village, Colorado, United States.
Who is the current CEO of Silvergate Pharma?
Frank Segrave is the current CEO of Silvergate Pharma.
Is Silvergate Pharma a funded company?
Silvergate Pharma is a funded company, having raised a total of $30.75M across 4 funding rounds to date. The company's 1st funding round was a Series B of $1M, raised on Jun 13, 2013.
What does Silvergate Pharma do?
Silvergate Pharmaceuticals was founded in 2010 and is based in Greenwood Village, United States. Operations focus on the pharmaceutical sector, with manufacturing centered on products for pediatric patients. A single product, Epaned, is currently available for treating high blood pressure in adults and children over one month old, symptomatic heart failure, and asymptomatic left ventricular dysfunction to reduce overt heart failure development and hospitalizations.
Who are the top competitors of Silvergate Pharma?
Silvergate Pharma's top competitors include Tenaya Therapeutics, Cellino and MyoKardia.
Who are Silvergate Pharma's investors?
Silvergate Pharma has 2 investors. Key investors include Frazier Healthcare Partners, and Azurity Pharmaceuticals.